To improve the diagnosis of invasive aspergillosis (IA), we retrospectively compared competitive polymerase chain reaction (PCR) and sandwich ELISA for detection of serum galactomannan (GM) antigen. We studied 281 serum samples collected weekly during the period at risk for IA from 41 selected hematology patients. Twenty-two patients had confirmed, probable, or suspected IA, according to clinical and mycologic data. 
New methods of diagnosing invasive aspergillosis are curProbably because of this better sensitivity, the main limitation of routine GM testing is false-positivity, which has ocrently being investigated to improve the ability to make the diagnosis noninvasively, particularly in high-risk patients.
curred at rates of 5.7% [9] , 19% [7] , and 29% [8] . When at least two consecutive positive tests have been required to consider a Problems in the diagnosis of invasive aspergillosis include the limited sensitivity of bronchoalveolar lavage (50% -60%) [1 - patient to be GM-positive, the false-positivity rate generally has decreased but only to 12% [10] or 16% [8] . False-positive 3] and the difficulty in interpreting a positive culture which could reflect contamination or colonization as well as invasive reactions are probably due to molecules that mimic the epitope infection. Both DNA detection by PCR [4] and antigen detecrecognized by the monoclonal antibody to GM [11] . Another tion tests [5] have been investigated, but their usefulness has possibility may be that aspergillosis occurs but then resolves been limited to date.
following recovery from neutropenia and treatment with amIn most studies of PCR, the method has been used on bronphotericin B, before confirmation of the diagnosis. choalveolar lavage (BAL) fluid samples and has been associWe postulated that using the competitive PCR test developed ated with a 10% -25% rate of false-positive results [4] , mainly in our laboratory [12] on patient serum concurrently with GM because PCR cannot distinguish between true infection, colonitesting could improve the specificity of GM detection. As the zation, and contamination of BAL samples by conidia. A posimolecules detected by the two techniques are completely differtive result of PCR on blood could be potentially more useful, ent, a GM-positive sample would be definitively positive for as colonization of blood is unlikely and contamination with Aspergillus if it were concurrently PCR-positive. Moreover, air-borne conidia should be avoidable when tubes are opened we studied the timing of positive tests to determine whether one under a laminar-air-flow hood.
could anticipate the other in making early diagnosis possible. Among the techniques based on antigen detection, the one used most has been the sandwich ELISA for detection of Aspergillus galactomannan (GM) antigen [6] . This antigen is secreted Patients and Methods in high amounts by the fungus. The detection threshold of the
Patients
ELISA is 1 ng of GM per mL of serum, an amount 10 times lower than the threshold of the commercial Pastorex Aspergil-A group of 41 hematology patients considered to have been lus latex kit (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, at high-risk for developing invasive aspergillosis were retroFrance) [7, 8] .
spectively selected from 1,213 patients seen on a hematology service over a 2 NOTE. ALL Å acute lymphocytic leukemia; AML Å acute myeloid leukemia; BAL Å bronchoalveolar lavage (fluid); CML Å chronic myelocytic leukemia; MD Å myelodysplasia. * C Å confirmed; P Å probable; S Å suspected.
Serological Tests
cal records were reviewed, and those considered to have clinical invasive aspergillosis were categorized according to the followSerum were collected at admission and at least once weekly ing criteria: (1) confirmed: histologically proven disease and for each patient at risk for invasive aspergillosis, as long as an Aspergillus-positive culture of a specimen obtained by perthe risk factors persisted. Serum samples were processed under cutaneous aspiration [13] ; (2) probable: development of a new a laminar-flow hood, heated at 56ЊC for 30 minutes, and split opacity in lung and isolation of an Aspergillus species or of into two aliquots; 2 mL was kept at 4ЊC for õ7 days until GM septate branched hyphae on a wet mount examination of BAL testing, and the remaining 2 mL was immediately stored at fluid, transtracheal aspirate, or sputum (or histologically proven 070ЊC for PCR. disease without any positive culture to confirm the species of ELISA was performed as previously described with plates filamentous fungus involved); and (3) suspected: temperature provided by Sanofi Diagnostics Pasteur (Platelia Aspergillus) of ú38ЊC for ú5 days that was unresponsive to antibacterial [10] . Each run contained a negative control (Tris-buffer saline agents, in a patient at risk for invasive aspergillosis who started alone) and two positive controls, containing 1 and 10 ng of receiving empirical antifungal treatment and had a new opacity GM per mL. The optical density results were converted into on a chest radiograph (no evident etiology).
GM concentrations expressed in ng/mL, as deduced from the On the basis of these criteria, 22 patients were considered to calibration curve obtained for each run. Positive samples conhave invasive aspergillosis (table 1), of whom 6 had confirmed tained a concentration of GM of §1 ng/mL. Although the invasive aspergillosis (patients 1 -6), 12 (patients 7 -18) had manufacturer recommends that the results should be expressed probable invasive aspergillosis, and 4 (patients 19 -22) had as an index (index õ1, negative; index ú1 and õ1.5, doubtful; suspected invasive aspergillosis. Nineteen patients did not deindex ú1.5, positive), we used quantitative results since the velop invasive aspergillosis. Three of them had fungal disease data are useful in evaluating the efficacy of treatment. other than aspergillosis, including one with invasive sinusitis
The frozen serum aliquots were coded and the amplification due to Scopulariopsis brevicaulis and two with fungemia due to Candida tropicalis.
was done blindly. After thawing, 200 mL of serum was pro-/ 9c4e$$ju14 05-13-98 05:35:16 cida UC: CID cessed with the QIAamp Blood Kit (Qiagen, Courtaboeuf, France). The DNA was finally eluted with 50 mL of 10-mM Tris-HCl (pH, 9.0), and 15 mL was used for the amplification reaction. The physical precautions taken to avoid contamination included the use of three different rooms for preparation of reaction media, DNA extraction, and PCR analysis, with use of positive pressure and adherence to usual recommendations [14] . The amplification reactions were performed with enzymatic prevention of carry-over by the systematic use of uracyl-N-glycosylase (UNG) and with detection of PCR inhibitors by an internal control, as previously described [12] . To differentiate the two main Aspergillus species responsible Roissy, France).
for aspergillosis (i.e., A. fumigatus and A. flavus), 1 mL of the The samples were initially incubated for 5 minutes at 50ЊC PCR products of positive samples was run on a 24-cm-long to allow the action of UNG. This incubation was followed by acrylamide urea gel (6% acrylamide, 8.3 M urea, and 1 1 TBE) a 10-minute step at 95ЊC to denature the DNA and to activate for 4 hours under 1,500 V. PCR signals were read with the the AmpliTaq Gold. The temperature cycling (45 cycles, at 94ЊC model 373 automated DNA sequencer (Applied Biosystems, and 55ЊC for 30 seconds each and 72ЊC for 1 minute) was Courtaboeuf, France) with an internal standard. The PCR prodperformed in a 48-well thermal cycler (Perkin Elmer Cetus).
uct for A. fumigatus was 157 bp and that for A. flavus was 140 Each amplification run contained several negative controls.
bp. Sequencing of two PCR products from reference strains The detection system uses fluorescence and is based on the (A. fumigatus IP 2279.94 and A. flavus IP 597.69) confirmed antifluorescein -alkaline phosphatase conjugate, which binds that the difference between the two DNA sequences was a 17-to the fluorescein of the amplified products. First, two 20-bp deletion in the A. flavus sequence (data not shown). To nucleotide probes within the amplified sequences but not overconfirm the specificity of the reaction, the DNA of collection lapping the primers were selected: the Aspergillus probe (5 strains was tested (Aspergillus niger IP 1431-83, Aspergillus GTA ATA GTA ACA TAG ATG GC 3) (nucleotides 873 -terreus IP 1136, Aspergillus nidulans IP 17-60, Aspergillus 892) and the internal probe specific for the M13mp18 sequence.
ustus 1587-85, Penicillium purporogenum 2281-94, and Both oligonucleotides were biotin-labeled to allow binding to S. brevicaulis IP 691-63); each of these reactions was negative. microplate wells by biotin streptavidin affinity.
The detection of PCR products was directly performed in Results wells of a streptavidin-coated microtitration plate (Boerhinger, Mannheim, Germany) as previously described [15] , except for A total of 281 serum samples from 41 patients were available for analysis (mean number of samples per patient, 6.9; range, the final stage, in which antifluorescein -alkaline phosphatase and 4 methylumbelliferylphosphate were substituted for anti-3 -20 samples). Thirty-two percent (90 of 281) were found to be GM-positive and 7% (20 of 281) were PCR-positive. All fluorescein-peroxidase and tetramethylbenzidine. The fluorescent signal was measured with a fluorimeter (MicroFluor; Dyof the PCR-positive samples and all but three GM-positive samples were from patients who were classified as having invanatech, Saint-Cloud, France) and was considered positive if it was five or more times the background control. A sample was sive aspergillosis (figure 1). Of the 18 patients with positive mycologic data, 14 (78%) had at least 2 GM-positive sera and considered positive if the signal with the Aspergillus probe was positive. A sample was considered negative only if the signal 9 (50%) had at least 1 PCR-positive serum.
/ 9c4e$$ju14 05-13-98 05:35:16 cida UC: CID B at the time of the first GM-positive result. In those cases in which PCR and mycologic results were positive, the length of the PCR products was in congruence with the Aspergillus species identified. Six patients met the criteria for confirmed invasive aspergillosis. All had multiple GM-positive samples, and two also had PCR-positive samples (patients 1 and 5). There were no positive mycologic data for patient 5 until shortly before death, but samples had been transiently GM-and PCR-positive 2 months earlier, in the setting of sinusitis treated with amphotericin B. The PCR-negative result was expected for patient 4, who had an A. ustus infection diagnosed following percutaneous aspiration of a pulmonary nodule. The GM antibody used in the sandwich ELISA is not specific for any Aspergillus species, and A. ustus DNA is not amplified in our PCR conditions. Twelve patients were classified as having probable invasive aspergillosis. Eight (patients 7 -14) had GM-positive samples, seven (patients 7 -12 and 14) had PCR-positive samples, and four (patients 15 -18) had GM-and PCR-negative samples. The data from patient 14 were informative, as the only mycologic findings were hyphae seen on wet-mount examination. The positive PCR result strongly suggested A. fumigatus as the fungus responsible. Data for two other patients (patients 15 and 16) were also informative, as they had repeatedly GMand PCR-negative samples, despite a sputum culture positive for A. fumigatus.
Patient 15 had acute leukemia and had had pneumonia (successfully treated with antibiotics) 2 months earlier. He developed a cavitary pulmonary nodule and underwent serological testing only during this second hospitalization. Patient 16 had bronchiolitis obliterans related to graft-vs.-host disease. The positivity of these patients' sputum for A. fumigatus could be explained by the colonization of previous pulmonary lesions. Unfortunately, both died and autopsies were not performed.
Four patients (patients 19 -22) were classified as having suspected aspergillosis. All were given empirical amphotericin B Figure 2 illustrates the timing of the positivity of these tests consistent with invasive aspergillosis. relative to the mycologic diagnosis of aspergillar infection.
All but one of the 19 patients with no evidence of aspergilloExcept for one sample that was simultaneously GM-negative sis had repeatedly GM-and PCR-negative samples. The one (patient 11), all the PCR-positive samples were also GM-posiexception had three consecutive positive GM titers measured tive. We noted that a PCR-positive signal was usually obtained and died with a cerebral tumor in which no fungal organism when a GM sample was highly positive (1 sample with GM was found at autopsy. These GM results were considered to titer of õ1 ng/mL; 3 with GM titers of §1 but õ3 ng/mL; 4 be falsely positive. The three patients with fungal disease other with GM titers of §3 but õ5 ng/mL; and 12 with GM titers than aspergillosis (one with invasive sinusitis caused by of §5 ng/mL).
S. brevicaulis and two with fungemia due to C. tropicalis) had Details concerning the 22 patients with a diagnosis of con-GM-and PCR-negative samples. firmed, probable, or suspected invasive aspergillosis are given Discussion in table 1. None of the 908 blood cultures for these patients was ever positive for Aspergillus species during the study pe-
In the present work we compared two new techniques, the double sandwich ELISA test for Aspergillus GM and a competriod. All patients were receiving treatment with amphotericin / 9c4e$$ju14 05-13-98 05:35:16 cida UC: CID itive PCR on blood samples from patients at high risk for and no positive PCR result was obtained for any patient with either nonaspergillar infection or no fungal infection. Thereinvasive aspergillosis. The findings of few studies of this kind have been published to date for comparison with our results.
fore, contamination is unlikely. The circulating DNA necessary to initiate amplification One study report described the simultaneous detection of GM and PCR products in BAL fluid samples [16] . From 35 nonneucould come from fungus that is unable to grow. This may explain the positive PCR obtained by investigators who extropenic patients, 5 and 2 samples were PCR-and GM-positive, respectively. Although it would be interesting to know whether tracted fungal DNA from the pellet obtained after cell lysis [18] ; then, the pellet would contain fungal hyphae. After protothe patients were colonized with an Aspergillus species, the high rate of false-positive results suggests to us that BAL fluid plast formation, the fungal DNA could be extracted and amplified. This seems to us highly unlikely in view of the ability of is not the best target for PCR and GM tests.
Other authors recently published a comparison between the A. fumigatus to grow on various media and the number of negative blood cultures. latex agglutination test, with use of the same monoclonal antibody as the GM ELISA, and a nested PCR of the 18S rRNA A more likely explanation for PCR-positive results is that Aspergillus DNA from dying hyphae is released into the blood, of A. fumigatus [17] . Twenty patients with histologically confirmed invasive aspergillosis were tested: 14 were PCR-positive as occurs in human cancers where mutant DNA from cancer cells is found in blood plasma [20] . As the half-life of circulating and 12 were GM-positive, but only 10 were positive in both tests. Although the timing of positivity during the course of DNA is short, probably less than 5 minutes [21], a positive PCR signal is observed only when the fungal burden is large enough aspergillosis was not given, this first report was important in showing that serum could be used to detect Aspergillus DNA to maintain at least 10 molecules of target DNA in 100 mL of serum, which is the sensitivity threshold of the PCR used. This in patients with invasive aspergillosis.
Comparison with our results is difficult, as the sensitivity of threshold is estimated by the amplification of the internal control systematically added in every clinical sample [12] . the sandwich ELISA we used is 10 times higher than that of latex agglutination [7, 8] . Moreover, the PCR techniques, the Thus, a positive PCR result would have the same meaning as a positive GM titer that increases with fungal burden. Indeed, DNA target, the sample processing, and the detection system used were completely different. In diagnostic PCR techniques, 12 of 20 positive PCR results were observed in association with GM titers of ú5 ng/mL. The fact that the GM assay was enzymatic prevention of contamination and detection of PCR inhibitors should be systematically included. Moreover, a more sensitive than PCR in our study could appear surprising to those who have considered PCR to be the ultimate sensitive nested PCR is too prone to contamination in a hospital laboratory when routine use is planned.
tool. However, neither the amounts of GM and of DNA released into the blood nor their clearance from blood are known. Recently, Einsele et al. reported on the use of a PCR technique on blood for the diagnosis of fungal disease [18] . They
If the clearance of DNA is faster than that of GM and if there is a huge quantity of GM released by the fungus, the better found 100% sensitivity for patients with invasive aspergillosis prior to treatment when two blood samples were considered.
sensitivity of the GM test would not be surprising. However, whether optimal results of PCR are obtained with the use of For the 8 patients who died, presumably of aspergillosis, the number of positive samples during the week before death was plasma, serum, buffy coat, or whole blood remains to be determined. only 8 of 12 (67%). This is in contrast with our findings for the six patients who died with aspergillosis and were both
The finding that neither test could predict the initiation of antifungal therapy was disappointing. This may be different PCR-and GM-positive. Samples were found to be positive before death for five of them, and all had negative tests at for nonhematology patients who are not systematically given amphotericin B for fever unresponsive to antibiotics. The emthe initiation of antifungal treatment. These data suggest a correlation of positive results with expansion of the fungal pirical treatment was probably responsible for the delay in the positivity of both tests. Nevertheless, although it is not possible burden despite therapy, which unfortunately is common in hematology patients.
to give any specificity, sensitivity, or predictive value of both tests since the patients were retrospectively selected, both tests While several studies have shown the usefulness of the GM antigenemia testing for the diagnosis and follow-up of invasive appear to be potentially useful for analyzing cases. The lack of false positives with PCR and the congruence of aspergillosis [6 -10] , the meaning of a positive PCR signal is less well established. Aspergillar fungemia is highly unusual the PCR signal with the species obtained in mycologic cultures showed that the specificity of the PCR is high. As the basis of [19] and was not observed in our patients. Therefore, the PCRpositive results may be surprising in view of the absence of the two tests are completely different, with one targeted at a polysaccharide and the other at a specific DNA sequence, a GMlive hyphae in the blood. The first explanation is that falsepositive results occur because of contamination. However, we positive test is definitively positive for us if confirmed by PCR. Thus, both tests appeared useful for the retrospective analysis took numerous precautions to avoid false-positive results in the present study, including the use of UNG enzymatic treatof medical files. Three patients in our study had suspected aspergillosis with positive GM and PCR tests and survived ment. The serum samples were coded and processed blindly, ing in a hospital laboratory. However, the specificity of the
